Related Experiment Video
Updated: Apr 3, 2026
10:55
Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy
Published on: October 31, 2025
1.0K
Immunological biomarkers in dermatomyositis.
Jeannette M Olazagasti1, Timothy B Niewold2, Ann M Reed3
1Division of Rheumatology, Mayo Clinic, 200 1st St SW, Rochester, MN, 55905, USA. olazagastilourido.jeannette@mayo.edu.
Current Rheumatology Reports
|September 26, 2015
Summary
Dermatomyositis (DM) is a chronic autoimmune disorder affecting muscles and skin. Recent research highlights novel immunological biomarkers for diagnosing and monitoring this complex disease.
Area of Science:
- Immunology
- Dermatology
- Rheumatology
Background:
- Dermatomyositis (DM) is a chronic autoimmune disorder impacting muscles and skin.
- Understanding DM pathogenesis and monitoring disease activity are critical research areas.
- Identifying reliable biomarkers is essential for effective patient management.
Purpose of the Study:
- To review recently discovered immunological biomarkers for DM.
- To discuss their potential in diagnosing and monitoring disease activity.
- To highlight advancements in understanding DM pathogenesis.
Main Methods:
- Literature review of recent studies on DM biomarkers.
- Analysis of immunological molecules implicated in DM.
- Synthesis of current research on biomarker discovery.
Main Results:
- Several novel molecules show promise as immunological biomarkers for DM.
- These biomarkers may aid in early diagnosis and disease activity monitoring.
- Research is actively identifying key players in DM pathogenesis.
Conclusions:
- Emerging immunological biomarkers offer new avenues for DM diagnosis and management.
- Continued research is vital for validating these biomarkers.
- Understanding molecular pathogenesis is key to improving therapeutic strategies for DM.
